Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein.

Yazaki PJ, Kassa T, Cheung CW, Crow DM, Sherman MA, Bading JR, Anderson AL, Colcher D, Raubitschek A.

Nucl Med Biol. 2008 Feb;35(2):151-8. doi: 10.1016/j.nucmedbio.2007.10.010.

PMID:
18312824
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent.

Dennis MS, Jin H, Dugger D, Yang R, McFarland L, Ogasawara A, Williams S, Cole MJ, Ross S, Schwall R.

Cancer Res. 2007 Jan 1;67(1):254-61.

PMID:
17210705
[PubMed - indexed for MEDLINE]
Free Article
3.

Tailoring antibodies for radionuclide delivery.

Kenanova V, Wu AM.

Expert Opin Drug Deliv. 2006 Jan;3(1):53-70. Review.

PMID:
16370940
[PubMed - indexed for MEDLINE]
4.

Arming antibodies: prospects and challenges for immunoconjugates.

Wu AM, Senter PD.

Nat Biotechnol. 2005 Sep;23(9):1137-46. Review.

PMID:
16151407
[PubMed - indexed for MEDLINE]
5.
6.

Albumin binding as a general strategy for improving the pharmacokinetics of proteins.

Dennis MS, Zhang M, Meng YG, Kadkhodayan M, Kirchhofer D, Combs D, Damico LA.

J Biol Chem. 2002 Sep 20;277(38):35035-43. Epub 2002 Jul 15.

PMID:
12119302
[PubMed - indexed for MEDLINE]
Free Article
7.

Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.

Yazaki PJ, Wu AM, Tsai SW, Williams LE, Ikler DN, Wong JY, Shively JE, Raubitschek AA.

Bioconjug Chem. 2001 Mar-Apr;12(2):220-8.

PMID:
11312683
[PubMed - indexed for MEDLINE]
8.

Numerical selection of optimal tumor imaging agents with application to engineered antibodies.

Williams LE, Wu AM, Yazaki PJ, Liu A, Raubitschek AA, Shively JE, Wong JY.

Cancer Biother Radiopharm. 2001 Feb;16(1):25-35.

PMID:
11279795
[PubMed - indexed for MEDLINE]
9.

Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis.

Viti F, Tarli L, Giovannoni L, Zardi L, Neri D.

Cancer Res. 1999 Jan 15;59(2):347-52.

PMID:
9927045
[PubMed - indexed for MEDLINE]
Free Article
10.

Kinetic and affinity constants of epitope specific anti-carcinoembryonic antigen (CEA) monoclonal antibodies for CEA and engineered CEA domain constructs.

Hefta LJ, Neumaier M, Shively JE.

Immunotechnology. 1998 Jun;4(1):49-57.

PMID:
9661814
[PubMed - indexed for MEDLINE]
11.

Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.

Wu AM, Chen W, Raubitschek A, Williams LE, Neumaier M, Fischer R, Hu SZ, Odom-Maryon T, Wong JY, Shively JE.

Immunotechnology. 1996 Feb;2(1):21-36.

PMID:
9373325
[PubMed - indexed for MEDLINE]
12.

Binding of serum albumin on tumor cells and characterization of the albumin binding protein.

Wang J, Ueno H, Masuko T, Hashimoto Y.

J Biochem. 1994 May;115(5):898-903.

PMID:
7961605
[PubMed - indexed for MEDLINE]
Free Article
13.

Monoclonal antibody radioimmunodetection of human-derived colon cancer.

Wahl RL, Philpott G, Parker CW.

Invest Radiol. 1983 Jan-Feb;18(1):58-62.

PMID:
6832932
[PubMed - indexed for MEDLINE]
14.

Immunological heterogeneity of carcinoembryonic antigen: purification from meconium of an antigen related to carcinoembryonic antigen.

Primus FJ, Freeman JW, Goldenberg DM.

Cancer Res. 1983 Feb;43(2):679-85.

PMID:
6401222
[PubMed - indexed for MEDLINE]
15.

Purification and characterization of carcinoembryonic antigens of the human digestive system.

Krupey J, Gold P, Freedman SO.

Nature. 1967 Jul 1;215(5096):67-8. No abstract available.

PMID:
6053407
[PubMed - indexed for MEDLINE]
16.

Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis.

Fägerstam LG, Frostell-Karlsson A, Karlsson R, Persson B, Rönnberg I.

J Chromatogr. 1992 Apr 24;597(1-2):397-410.

PMID:
1517343
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk